Genetic Technologies Limited (ASX:GTG)
Australia · Delayed Price · Currency is AUD 0.0390
0.00 (0.00%)
Oct 16, 2024, 1:07 PM AEST
Genetic Technologies Market Cap
Genetic Technologies has a market cap or net worth of 5.67 million as of July 28, 2025. Its market cap has decreased by -75.43% in one year.
Market Cap
5.67M
Enterprise Value
5.51M
Revenue
9.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since September 5, 1994, Genetic Technologies's market cap has increased from 3.80M to 5.67M, an increase of 49.21%. That is a compound annual growth rate of 1.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2024 | 5.67M | -63.60% |
| Dec 29, 2023 | 15.58M | -43.75% |
| Dec 30, 2022 | 27.70M | -40.00% |
| Dec 31, 2021 | 46.17M | -25.49% |
| Dec 31, 2020 | 61.96M | 177.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.02B |
| Pro Medicus | 33.52B |
| Cochlear | 20.46B |
| Sonic Healthcare | 13.95B |
| Ramsay Health Care | 8.87B |
| Telix Pharmaceuticals | 7.14B |
| Ansell | 4.47B |
| Mesoblast | 3.19B |